Follow
Sandra Dakdouk Isidean
Sandra Dakdouk Isidean
Verified email at mail.mcgill.ca
Title
Cited by
Cited by
Year
A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression
SD Isidean, MS Riddle, SJ Savarino, CK Porter
Vaccine 29 (37), 6167-6178, 2011
2552011
A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC)
CK Porter, MS Riddle, DR Tribble, AL Bougeois, R McKenzie, SD Isidean, ...
Vaccine 29 (35), 5869-5885, 2011
812011
Human papillomavirus testing versus cytology in primary cervical cancer screening: End‐of‐study and extended follow‐up results from the Canadian cervical cancer screening trial
SD Isidean, MH Mayrand, AV Ramanakumar, L Gilbert, SL Reid, ...
International journal of cancer 139 (11), 2456-2466, 2016
762016
Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy
EL Franco, S de Sanjosé, TR Broker, MA Stanley, M Chevarie-Davis, ...
Vaccine 30, F175-F182, 2012
562012
Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects
DR Tribble, S Baqar, MP Carmolli, C Porter, KK Pierce, K Sadigh, ...
Clinical infectious diseases 49 (10), 1512-1519, 2009
502009
Comparison of triage strategies for HPV-positive women: Canadian cervical cancer screening trial results
SD Isidean, MH Mayrand, AV Ramanakumar, I Rodrigues, A Ferenczy, ...
Cancer Epidemiology, Biomarkers & Prevention 26 (6), 923-929, 2017
322017
cobas® 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens
SD Isidean, F Coutlée, EL Franco
Expert review of molecular diagnostics 14 (1), 5-16, 2014
302014
Embracing a new era in cervical cancer screening
SD Isidean, EL Franco
The Lancet 383 (9916), 493-494, 2014
272014
Counterpoint: cervical cancer screening guidelines—approaching the golden age
SD Isidean, EL Franco
American journal of epidemiology 178 (7), 1023-1026, 2013
212013
Defining benchmarks for tolerable risk thresholds in cancer screening: Impact of HPV vaccination on the future of cervical cancer screening
JE Tota, SD Isidean, EL Franco
International Journal of Cancer 147 (12), 3305-3312, 2020
162020
Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs
SD Isidean, JE Tota, JA Gagnon, EL Franco
Expert Review of Vaccines 14 (1), 119-133, 2015
142015
Impact of international travel and diarrhea on gut microbiome and resistome dynamics
M Boolchandani, KS Blake, DH Tilley, MM Cabada, DJ Schwartz, S Patel, ...
Nature communications 13 (1), 7485, 2022
112022
A systematic review and meta-analysis of Penner serotype prevalence of Campylobacter jejuni in low- and middle-income countries
TN Clarke, MA Schilling, LA Melendez, SD Isidean, CK Porter, FM Poly
Plos one 16 (5), e0251039, 2021
102021
Exploring Changes in the Host Gut Microbiota During a Controlled Human Infection Model for Campylobacter jejuni
BW Stamps, J Kuroiwa, SD Isidean, MA Schilling, C Harro, KR Talaat, ...
Frontiers in Cellular and Infection Microbiology 11, 702047, 2021
72021
An elusive low-hanging fruit for public health: gun violence prevention.
EL Franco, GA Shinder, JE Tota, SD Isidean
Preventive medicine 79, 1-2, 2015
72015
A pooled analysis to compare the clinical characteristics of human papillomavirus–positive and-negative cervical precancers
PE Castle, AJ Pierz, R Adcock, S Aslam, PS Basu, JL Belinson, J Cuzick, ...
Cancer Prevention Research 13 (10), 829-840, 2020
62020
Assessing the time dependence of prognostic values of cytology and human papillomavirus testing in cervical cancer screening
SD Isidean, Y Wang, MH Mayrand, S Ratnam, F Coutlée, EL Franco, ...
International Journal of Cancer 144 (10), 2408-2418, 2019
62019
Clinical performance of the BD Onclarity extended genotyping assay for the management of women positive for human papillomavirus in cervical cancer screening
KD Volesky, S Magnan, MH Mayrand, SD Isidean, M El-Zein, E Comète, ...
Cancer Epidemiology, Biomarkers & Prevention 31 (4), 851-857, 2022
52022
The Controlled Human Infection Model for Enterotoxigenic Escherichia coli
CK Porter, KR Talaat, SD Isidean, A Kardinaal, S Chakraborty, ...
42021
Changes on the horizon for cervical cancer screening.
SD Isidean, GA Shinder
Preventive Medicine 98, 1-2, 2016
42016
The system can't perform the operation now. Try again later.
Articles 1–20